Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


08.01.2024

3 Acta Neuropathol
1 Am J Geriatr Psychiatry
8 J Alzheimers Dis
1 J Neurol
1 N Engl J Med
1 Nature
2 Neurobiol Aging
8 Neurology
1 Neurosci Lett


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. MONTOLIU-GAYA L, Alosco ML, Yhang E, Tripodis Y, et al
    Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
    Acta Neuropathol. 2023;147:5.
    PubMed         Abstract available

  2. TAYLOR LW, Simzer EM, Pimblett C, Lacey-Solymar OTT, et al
    p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.
    Acta Neuropathol. 2024;147:7.
    PubMed         Abstract available

  3. AGRA ALMEIDA QUADROS AR, Li Z, Wang X, Ndayambaje IS, et al
    Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
    Acta Neuropathol. 2024;147:9.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  4. ZHAI Z, Kong F, Zhu Z, Dai J, et al
    Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Am J Geriatr Psychiatry. 2023 Dec 7:S1064-7481(23)00491.
    PubMed         Abstract available


    J Alzheimers Dis

  5. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
    Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
    PubMed         Abstract available

  6. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
    Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
    PubMed         Abstract available

  7. ALMKVIST O, Larsson M, Graff C
    Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
    PubMed         Abstract available

  8. FAN X, Li H, Liu L, Zhang K, et al
    Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
    PubMed         Abstract available

  9. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
    Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
    PubMed         Abstract available

  10. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
    Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
    PubMed         Abstract available

  11. ZHANG E, Dai F
    Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
    J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
    PubMed         Abstract available

  12. MAHZARNIA A, Lutz MW, Badea A
    A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
    PubMed         Abstract available


    J Neurol

  13. MASSA F, Martinuzzo C, Gomez de San Jose N, Pelagotti V, et al
    Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    J Neurol. 2023 Dec 29. doi: 10.1007/s00415-023-12154.
    PubMed         Abstract available


    N Engl J Med

  14. REZAI AR, D'Haese PF, Finomore V, Carpenter J, et al
    Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease.
    N Engl J Med. 2024;390:55-62.
    PubMed         Abstract available


    Nature

  15. LOVESTAM S, Li D, Wagstaff JL, Kotecha A, et al
    Disease-specific tau filaments assemble via polymorphic intermediates.
    Nature. 2024;625:119-125.
    PubMed         Abstract available


    Neurobiol Aging

  16. AI M, Morris TP, Noriega de la Colina A, Thovinakere N, et al
    Midlife physical activity engagement is associated with later-life brain health.
    Neurobiol Aging. 2024;134:146-159.
    PubMed         Abstract available

  17. LEVIN F, Grothe MJ, Dyrba M, Franzmeier N, et al
    Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease.
    Neurobiol Aging. 2023;135:26-38.
    PubMed         Abstract available


    Neurology

  18. ZANON ZOTIN MC, Makkinejad N, Schneider JA, Arfanakis K, et al
    Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample.
    Neurology. 2024;102:e207940.
    PubMed         Abstract available

  19. HANSEEUW BJ, Jacobs HIL, Schultz AP, Buckley RF, et al
    Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
    Neurology. 2023;101:e2533-e2544.
    PubMed         Abstract available

  20. LOOMIS SJ, Miller R, Castrillo-Viguera C, Umans K, et al
    Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies.
    Neurology. 2024;102:e207919.
    PubMed         Abstract available

  21. HARDY J, Schott JM
    Identifying Genetic Risk for Amyloid-Related Imaging Abnormalities.
    Neurology. 2024;102:e208096.
    PubMed         Abstract available

  22. PEROSA V, Zanon Zotin MC, Schoemaker D, Sveikata L, et al
    Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy.
    Neurology. 2024;102:e207854.
    PubMed         Abstract available

  23. LOPEZ OL, Villemagne VL, Chang YF, Cohen AD, et al
    Association Between beta-Amyloid Accumulation and Incident Dementia in Individuals 80 Years or Older Without Dementia.
    Neurology. 2024;102:e207920.
    PubMed         Abstract available

  24. DUBBELMAN MA, Hendriksen HMA, Harrison JE, Vijverberg EGB, et al
    Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups.
    Neurology. 2024;102:e207978.
    PubMed         Abstract available

  25. CASTILHOS RM, Snitz BE
    Longitudinal Cognitive Decline in Alzheimer Disease Prevention Trials.
    Neurology. 2024;102:e208067.
    PubMed         Abstract available


    Neurosci Lett

  26. ZHANG Y, Shen S, Li X, Wang S, et al
    A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer's disease prediction.
    Neurosci Lett. 2023;821:137609.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.